Research ArticleBehavioral Pharmacology
Assessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse Potential
A. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. Brennan
Journal of Pharmacology and Experimental Therapeutics October 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
A. J. Brock
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom (A.J.B., A.S., C.H.B.); Global Safety Pharmacology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut (S.M.G.G., A.N.M.); and School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, United Kingdom (M.O.P.)
S. M. G. Goody
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom (A.J.B., A.S., C.H.B.); Global Safety Pharmacology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut (S.M.G.G., A.N.M.); and School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, United Kingdom (M.O.P.)
A. N. Mead
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom (A.J.B., A.S., C.H.B.); Global Safety Pharmacology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut (S.M.G.G., A.N.M.); and School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, United Kingdom (M.O.P.)
A. Sudwarts
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom (A.J.B., A.S., C.H.B.); Global Safety Pharmacology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut (S.M.G.G., A.N.M.); and School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, United Kingdom (M.O.P.)
M.O. Parker
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom (A.J.B., A.S., C.H.B.); Global Safety Pharmacology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut (S.M.G.G., A.N.M.); and School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, United Kingdom (M.O.P.)
C.H. Brennan
School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom (A.J.B., A.S., C.H.B.); Global Safety Pharmacology, Drug Safety Research and Development, Pfizer Worldwide Research and Development, Groton, Connecticut (S.M.G.G., A.N.M.); and School of Health Sciences and Social Work, University of Portsmouth, Portsmouth, United Kingdom (M.O.P.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBehavioral Pharmacology
Assessing Zebrafish CPP for Predicting Human Abuse Potential
A. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. Brennan
Journal of Pharmacology and Experimental Therapeutics October 1, 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Research ArticleBehavioral Pharmacology
Assessing Zebrafish CPP for Predicting Human Abuse Potential
A. J. Brock, S. M. G. Goody, A. N. Mead, A. Sudwarts, M.O. Parker and C.H. Brennan
Journal of Pharmacology and Experimental Therapeutics October 1, 2017, 363 (1) 66-79; DOI: https://doi.org/10.1124/jpet.117.242628
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement